SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

BioCardia, Inc. – ‘CORRESP’ from 12/1/23

On:  Friday, 12/1/23, at 6:30am ET   ·   Delayed-Release:  Filing  –  Release Delayed   ·   Accession #:  1437749-23-33315

Previous ‘CORRESP’:  ‘CORRESP’ on 11/15/23   ·   Latest ‘CORRESP’:  This Filing

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/01/23  BioCardia, Inc.                   CORRESP1/08/24    1:13K                                    RDG Filings/FA

Comment-Response or Other Letter to the SEC   —   Delayed-Release

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: CORRESP     Comment-Response or Other Letter to the SEC         HTML     12K

This is an HTML Document rendered as filed.  [ Alternative Formats ]

  bcda20231129_corresp.htm  
 C:  <>  <> 

 

BioCardia, Inc.

320 Soquel Way

Sunnyvale, California 94085

 

December 1, 2023

 

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Cindy Polynice

 

 

Re:

BioCardia, Inc.
 

Registration Statement on Form S-3
 

File No. 333-275099

 

 

Acceleration Request

Requested Date:             December 5, 2023

Requested Time:            4:30 p.m., Eastern Time

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-275099) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with the Company’s counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin March at (512) 338-5410.

 

[Signature page follows]

 

 
 

 

 

Sincerely, 

 
     
  BioCardia, Inc.  

 

 

 

 

 

/s/ Peter Altman

 
  Peter Altman  
 

President and Chief Executive Officer and

Director

  

 

  cc: 

David McClung, BioCardia, Inc.
   

Michael J. Danaher, Wilson Sonsini Goodrich & Rosati, P.C.
   

Austin D. March, Wilson Sonsini Goodrich & Rosati, P.C.

 

 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘CORRESP’ Filing    Date    Other Filings
12/5/238-K,  8-K/A,  EFFECT
Filed on:12/1/23
 List all Filings 
↑Top
Filing Submission 0001437749-23-033315   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., Apr. 27, 5:26:22.1pm ET